The influence of the explant technique on the hemodynamic profile during sequential domino liver transplantation in familial amyloid polyneuropathy patients

Liver Transplantation

Volumn 15, Issue 8, 2009, Pages 869-875

  Escobar, Bibiana ^a   Taura, Pilar ^a   Barreneche, Nelson ^a   Beltran, Joan ^a   Balust, Jaume ^a   Martinez Palli, Graciela ^a   Zavala, Elizabeth ^a   Escorsell, Angels ^a   Garcia Valdecasas, Juan Carlos ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIARRHYTHMIC AGENT; VASOACTIVE AGENT;

ADULT; ARTICLE; AUTONOMIC DYSFUNCTION; BLEEDING; BLOOD TRANSFUSION; CARDIOPULMONARY HEMODYNAMICS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EXPLANT; FAMILIAL AMYLOID POLYNEUROPATHY; FEMALE; HEART ARRHYTHMIA; HEART DISEASE; HEART FAILURE; HUMAN; HYPERTENSION; INFERIOR CAVA VEIN; INTERMETHOD COMPARISON; KIDNEY DISEASE; LIVER TRANSPLANTATION; MALE; PERIPHERAL NEUROPATHY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SURGICAL TECHNIQUE; SURVIVAL RATE; TREATMENT OUTCOME; VASCULAR SURGERY; VEIN BYPASS; VENA CAVA PRESERVATION;

EID: 69949111698     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21772     Document Type: Article

References (32)

1. Ando Y, Nakamura M, Araki S. Transthyretin-related familial amyloidotic polyneuropathy. Arch Neurol 2005;62: 1057-1062.
2. Benson MD, Kincaid JC. The molecular biology and clinical features of amyloid neuropathy. Muscle Nerve 2007; 36:411-423.
3. Shah KB, Inoue Y, Mehra MR. Amyloidosis and the heart: a comprehensive review. Arch Intern Med 2006;166:1805-1813.
4. Volpi A, Cavalli A, Maggioni AP, Matturri L, Rossi L. Cardiac amyloidosis involving the conduction system and the aortocoronary neuroreceptors. Clinicopathologic correlates. Chest 1986;90:619-621.
5. Ando Y. Liver transplantation and new therapeutic approaches for familial amyloidotic polyneuropathy (FAP). Med Mol Morphol 2005;38:142-154.
6. Herlenius G, Wilczek HE, Larsson M, Ericzon BG, and the Familial Amyloidotic Polyneuropathy World Transplant Registry. Ten years of international experience with liver transplantation for familial amyloidotic polyneuropathy: results from the Familial Amyloidotic Polyneuropathy World Transplant Registry. Transplantation 2004;77:64-71.
7. Yamamoto S, Wilczek HE, Nowak G, Larsson M, Oksanen A, Iwata T, et al. Liver transplantation for familial amyloidotic polyneuropathy (FAP): a single-center experience over 16 years. Am J Transplant 2007;7:2597-2604.
8. Delahaye N, Rouzet F, Sarda L, Tamas C, Dinanian S, Plante-Bordeneuve V, et al. Impact of liver transplantation on cardiac autonomic denervation in familial amyloid polyneuropathy. Medicine (Baltimore) 2006;85:229-238.
9. Neelakanta G, Mahajan A, Antin C. Systemic vasodilation is a predominant cause of hypotension in a patient with familial amyloid polyneuropathy during liver transplantation. J Clin Anesth 2005;17:202-204.
10. Viana JS, Bento C, Vieira H, Neves S, Seco C, Perdigoto R, et al. Requirements of circulatory support during liver transplantation: are patients with familial amyloidosis different from other patients? Transplant Proc 2000;32: 2652-2653.
11. Furtado AJ. Domino liver transplantation using FAP grafts. HUC experience-hopes and realities. Amyloid 2003;10(suppl 1):84-87.
12. Golling M, Singer R, Weiss G, Mehrabi A, Zapletal C, Kraus T, et al. Sequential (domino) transplantation of the liver in a transthyretin-50 familial amyloid polyneuropathy. Special reference to cardiological diagnosis and complications. Langenbecks Arch Surg 2000;385:21-26.
13. Hemming AW, Cattral MS, Chari RS, Greig PD, Lilly LB, Ashby P, et al. Domino liver transplantation for familial amyloid polyneuropathy. Liver Transpl Surg 1998;4:236-238.
14. Yamamoto S, Wilczek HE, Iwata T, Larsson M, Gjertsen H, Soderdahl G, et al. Long-term consequences of domino liver transplantation using familial amyloidotic polyneuropathy grafts. Transpl Int 2007;20:926-933.
15. Gonzalez FX, Garcia-Valdecasas JC, Grande L, Pacheco JL, Cugat E, Fuster J, et al. Vena cava vascular reconstruction during orthotopic liver transplantation: a comparative study. Liver Transpl Surg 1998;4:133-140.
16. Jabbour N, Gagandeep S, Genyk Y, Selby R, Mateo R. Caval preservation with reconstruction of the hepatic veins using caval-common iliac bifurcation graft for domino liver transplantation. Liver Transpl 2006;12:324-325.
17. Khan S, Silva MA, Tan YM, John A, Gunson B, Buckels JA, et al. Conventional versus piggyback technique of caval implantation; without extra-corporeal veno-venous bypass. A comparative study. Transpl Int 2006;19:795-801.
18. Mangus RS, Kinsella SB, Nobari MM, Fridell JA, Vianna RM, Ward ES, et al. Predictors of blood product use in orthotopic liver transplantation using the piggyback hepatectomy technique. Transplant Proc 2007;39:3207-3213.
19. Rossi G, Langer M, Maggi U, Reggiani P, Caccamo L, Gatti S, et al. Veno-venous bypass versus no bypass in orthotopic liver transplantation: hemodynamic, metabolic, and renal data. Transplant Proc 1998;30:1871-1873.
20. Barrio IM, Mtnez de Guerenu MA, Real MI, Del Campo I, Perez-Cerda F, Moreno E. Anesthetic management of a combined heart and liver transplantation in an amyloidotic patient: a case report. Transplant Proc 2007;39:2458-2459.
21. Acosta F, Sansano T, Rodriguez MA, Contreras RF, Reche M, Beltran R, et al. Need for venovenous bypass in patients with familial amyloidotic polyneuropathy treated with liver transplantation. Transplant Proc 1999;31: 2394-2395.
22. Grazi GL, Cescon M, Salvi F, Ercolani G, Ravaioli M, Arpesella G, et al. Combined heart and liver transplantation for familial amyloidotic neuropathy: considerations from the hepatic point of view. Liver Transpl 2003;9:986-992.
23. Pilato E, Dell'Amore A, Botta L, Arpesella G. Combined heart and liver transplantation for familial amyloidotic neuropathy. Eur J Cardiothorac Surg 2007;32:180-182.
24. Te HS, Anderson AS, Millis M, Jeevanandam V, Jensen DM. Current state of combined heart-liver transplantation in the United States. J Heart Lung Transplant 2008;27: 753-759.
25. Hilmi IA, Planinsic RM. Con: venovenous bypass should not be used in orthotopic liver transplantation. J Cardiothorac Vasc Anesth 2006;20:744-747.
26. Reddy K, Mallett S, Peachey T. Venovenous bypass in orthotopic liver transplantation: time for a rethink? Liver Transpl 2005;11:741-749.
27. Grande L, Rimola A, Cugat E, Alvarez L, Garcia-Valdecasas JC, Taura P, et al. Effect of venovenous bypass on perioperative renal function in liver transplantation: results of a randomized, controlled trial. Hepatology 1996; 23:1418-1428.
28. Nowak G, Suhr OB, Wikstrom L, Wilczek H, Ericzon BG. The long-term impact of liver transplantation on kidney function in familial amyloidotic polyneuropathy patients. Transpl Int 2005;18:111-115.
29. Snanoudj R, Durrbach A, Gauthier E, Adams D, Samuel D, Ferlicot S, et al. Changes in renal function in patients with familial amyloid polyneuropathy treated with orthotopic liver transplantation. Nephrol Dial Transplant 2004; 19:1779-1785.
30. Holmgren G, Ericzon BG, Groth CG, Steen L, Suhr O, Andersen O, et al. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet 1993;341:1113-1116.
31. Jonsen E, Suhr OB, Tashima K, Athlin E. Early liver transplantation is essential for familial amyloidotic polyneuropathy patients' quality of life. Amyloid 2001;8:52-57.
32. Lewis WD. Liver transplant and familial amyloidotic polyneuropathy. Liver Transpl 2002;8:1085-1087.